166 related articles for article (PubMed ID: 37564740)
1. Successful Treatment of
Pechacek J; Webb T; Ferré EMN; Schmitt MM; DiMaggio T; Kobrin D; Rajasimhan S; Colton B; Lewis RE; Andes D; Herrera A; Hammoud D; Seyedmousavi S; Hasni S; Bolaños J; Afzali B; Lionakis MS
Open Forum Infect Dis; 2023 Aug; 10(8):ofad410. PubMed ID: 37564740
[No Abstract] [Full Text] [Related]
2. Treatment of Paecilomyces variotii pneumonia with posaconazole: case report and literature review.
Feldman R; Cockerham L; Buchan BW; Lu Z; Huang AM
Mycoses; 2016 Dec; 59(12):746-750. PubMed ID: 27401982
[TBL] [Abstract][Full Text] [Related]
3. A Case of Pulmonary Mycetoma Caused by
Marques DP; Carvalho J; Rocha S; Domingos R
Eur J Case Rep Intern Med; 2019; 6(2):001040. PubMed ID: 30931270
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis. How long? How much?
Beimler JH; Andrassy K
Pediatr Nephrol; 2004 Sep; 19(9):949-55. PubMed ID: 15257454
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive treatment for proliferative lupus nephritis.
Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
[TBL] [Abstract][Full Text] [Related]
8. Disseminated Intravascular Infection Caused by
Lazarus JE; Branda JA; Gandhi RG; Barshak MB; Zachary KC; Barczak AK
Open Forum Infect Dis; 2020 Jun; 7(6):ofaa166. PubMed ID: 32617367
[No Abstract] [Full Text] [Related]
9.
Asif AA; Roy M; Ahmad S
Eur J Case Rep Intern Med; 2021; 8(7):002651. PubMed ID: 34268271
[No Abstract] [Full Text] [Related]
10. Identification of Paecilomyces variotii in clinical samples and settings.
Houbraken J; Verweij PE; Rijs AJ; Borman AM; Samson RA
J Clin Microbiol; 2010 Aug; 48(8):2754-61. PubMed ID: 20519470
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
[TBL] [Abstract][Full Text] [Related]
12. Pro: Cyclophosphamide in lupus nephritis.
Kallenberg CG
Nephrol Dial Transplant; 2016 Jul; 31(7):1047-52. PubMed ID: 27190359
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
14. Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope® registry and literature reports.
Sprute R; Salmanton-García J; Sal E; Malaj X; Falces-Romero I; Hatvani L; Heinemann M; Klimko N; López-Soria L; Meletiadis J; Shruti M; Steinmann J; Seidel D; Cornely OA; Stemler J
J Antimicrob Chemother; 2021 Feb; 76(3):765-774. PubMed ID: 33254240
[TBL] [Abstract][Full Text] [Related]
15. Treatment for lupus nephritis.
Henderson L; Masson P; Craig JC; Flanc RS; Roberts MA; Strippoli GF; Webster AC
Cochrane Database Syst Rev; 2012 Dec; 12():CD002922. PubMed ID: 23235592
[TBL] [Abstract][Full Text] [Related]
16. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
18. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
Morović-Vergles J; Galesić K; Dancuo I; Vergles D
Acta Med Croatica; 2004; 58(1):13-7. PubMed ID: 15125388
[TBL] [Abstract][Full Text] [Related]
19. Intravenous cyclophosphamide in lupus nephritis.
Leondike MR; Shattuck MA
J Intraven Nurs; 1993; 16(1):23-7. PubMed ID: 8437043
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of Paecilomyces lilacinus keratitis with oral posaconazole.
Arnoldner MA; Kheirkhah A; Jakobiec FA; Durand ML; Hamrah P
Cornea; 2014 Jul; 33(7):747-9. PubMed ID: 24858020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
